Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:7 Issue:8 Number:9 ISSN#:2563-5476
ACE Report #11950
Ace Report Cover Sports Medicine

Benefit of BM-MSC addition in core decompression in treatment of osteonecrosis of the femoral head

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis

Int J Surg. 2019 Jul 10;69:23-31

Contributing Authors: Z Wang QM Sun FQ Zhang QL Zhang LG Wang WJ Wang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


14 randomized controlled trials were included in this meta-analysis which sought to investigate the impact of autologous bone marrow-derived mesenchymal stem cell (MSC) administration alongside core decompression on outcomes in treatment of patients with osteonecrosis of the femoral head. Pooled analyses of pain scores from 6 months to 2 years, function from 1 to 2 years, and incidence of eventual...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.